Soon Wei Wong

Soon Wei Wong

Auto-generated profile, based on publicly available information

Soon Wei Wong

College of Medicine and Public Health, Flinders University, Adelaide, Australia

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2026 in Nature Immunology
Verified
Journal Article
Open access
PDF file
KBKartik Bhamidipati
Kartik Bhamidipati
AMAlexa B. R. McIntyre
Alexa B. R. McIntyre
SKShideh Kazerounian
Shideh Kazerounian
GCGao Ce
Gao Ce
SWSoon W. Wong
Soon W. Wong
KWKevin Wei
Kevin Wei
Treatment-refractory rheumatoid arthritis (RA) is a major unmet need, and the underlying mechanisms are poorly understood. To identify molecular determinants of refractory RA, we performed spatial transcriptomic profiling on synovial tissue biopsy samples taken 6 months before and after treatment. In the baseline biopsy samples of non-remitting patients, we identified increased fibrogenic signaling within vascular tissue niches, marked by high fibroblast COMP expression. We uncovered a role of endothelial-derived Notch signaling as an upstream regulator of fibroblast transforming growth factor beta (TGFβ) signaling via its opposing ability to induce TGFβ isoform expression while suppressing TGFβ receptors, generating a proximal-to-distal gradient of TGFβ sensitivity that can be altered with disruption of steady-state Notch signaling. In posttreatment biopsy samples, we observed significant immune depletion with expansion of fibrogenic niches, a process that can be reversed by inhibition of Notch and TGFβ signaling in RA patient-derived organoids. Collectively, our data implicate targeting of TGFβ signaling to prevent exuberant synovial tissue fibrosis as a potential therapeutic strategy for refractory RA.

25 January 2025 in Current Rheumatology Reports
Verified
Journal Article
Open access
PDF file
ACAthena Chin
Athena Chin
ASAnnabelle Grace Small
Annabelle Grace Small
SWSoon Wei Wong
Soon Wei Wong
MWMihir D Wechalekar
Mihir D Wechalekar
Purpose of Review: Rheumatoid arthritis (RA) is a complex autoimmune disease characterized by chronic inflammation of the synovial tissue, where T cells play a central role in pathogenesis. Recent research has identified T peripheral helper (Tph) cells as critical mediators of local B cell activation in inflamed tissues. This review synthesizes the latest advancements in our understanding the of the role of T cells in RA, from initiation to established disease. Recent Findings: We explore recent advances regarding the genetic and epigenetic factors that predispose individuals to RA, the mechanisms of T cell activation and differentiation, and the interactions between T cells and other immune and stromal cells within the synovial microenvironment. The emergence of Tph cells as key drivers of RA pathobiology is highlighted, along with their potential as therapeutic targets. We also discuss the heterogeneity of T cell responses and their interplay with synovial cells, while addressing critical research gaps such as the drivers of T cell recruitment and the plasticity of synovial phenotypes. Summary: A deeper understanding of T cell dynamics in RA will provide valuable insights for developing targeted therapies to modulate T cell-mediated inflammation and improve patient outcomes.

14 August 2025 in Kidney360
Verified
Journal Article
Open access
Amita BansalAmita Bansal
Amita Bansal
SWSoon Wei Wong
Soon Wei Wong
WWWilson K.M. Wong
Wilson K.M. Wong
OBOliver Giles Best
Oliver Giles Best
SJSteven James
Steven James
EEElif.I. Ekinci
Elif.I. Ekinci
Key Points: Regulatory T cells (Tregs) from people (control, type 1 diabetes with and without albuminuria) were profiled for phenotypic and transcriptomic changes. Central memory Tregs were reduced, while Treg EMRA + cells were higher in type 1 diabetes with albuminuria. In silico findings suggest potential interactions between Treg ligand and kidney cell receptor at transcript level. Background: Diabetic kidney disease (DKD) is a common complication of type 1 diabetes (T1D). T1D and some kidney disorders are often associated with abnormalities in regulatory T cells (Tregs). However, it is unknown if Treg subsets and their molecular architecture are altered during the onset and progression of DKD in T1D. Methods: We addressed this critical knowledge gap by characterizing changes in Tregs isolated from 31 participants (10 control, 13 with T1D, and eight T1D with albuminuria) using flow cytometry, RNA-sequencing, and microRNA profiling. Results: We identified that the effector and central memory Tregs were significantly different between groups. Similarly, multiple gene transcripts were also significantly different between groups that also overlapped with other publicly available datasets. Machine learning–based data analyses discovered a set of important microRNAs associated with clinical eGFR values. Importantly, our analyses identified two differentially expressed Treg ligand genes (leucine rich repeat containing 4B, transglutaminase-2), which interacted with the receptors on kidney cells (protein tyrosine phosphatase receptor type D/F/S, Adhesion G Protein-Coupled Receptor G1; a.k.a GPR56) in silico , providing potential mechanistic insights into the role of Tregs in DKD progression. Conclusions: Together, our work supports the yet unappreciated role of Tregs in DKD and opens new research avenues to further consolidate their causal relationship.

30 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
Jia Yi HeeJia Yi Hee
Jia Yi Hee
HNHendrik J Nel
Hendrik J Nel
OROxana Radetskaya
Oxana Radetskaya
GAGabrielle Antonio-Carreon
Gabrielle Antonio-Carreon
CCCarl Coyle
Carl Coyle
RTRanjeny Thomas
Ranjeny Thomas
Objective: In the first year after onset of the autoimmune disease RA (RA), 40-60% do not achieve remission on conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs). To understand how autoreactive T cells may contribute to unstable or non-remission, we studied CD4+ T cells, including those recognising citrullinated (Cit) vimentin in participants with RA. Methods: Two cohorts of drug-naïve new-onset participants with RA were treated with csDMARDs. Disease activity score (DAS28-CRP) and peripheral blood (PB) mononuclear cells were collected longitudinally. In HLA-DR-shared epitope+ cohort 1 (n=21), T cells were assessed with a 17-marker spectral flow panel, incorporating HLA-DRB1*04:01/01:01- VimentinCit64 59-71 or HLA-DRB1*04:04-VimentinCit71 66-78 tetramers. Changes in T cell subsets over time were assessed in remitting and non-remitting participants using a generalized linear mixed model with a negative binomial distribution. In cohort 2 (n=26), the transcriptome of disaggregated synovial tissue (ST) and PB CD4+ T cells were analysed at baseline, and ST biopsy spatial proteomics at baseline and 6 months. Results: CD4⁺CXCR5 - PD1 + peripheral helper T cells (Tph), including Cit-vimentin-reactive Tph, CD4⁺CCR7 + CXCR5 - PD1 + stem-like Tph and TIGIT+PD1+ Tph were increased with moderate/high DAS28-CRP at any time point. Remission outcome was associated with low CD4⁺ follicular helper T cell (Tfh) and Cit-vimentin-reactive Tfh. In non-remitting participants, Tph/fh infiltrated germinal-centre-like ST aggregates. This decreased in remission. Circulating TIGIT + Tph genes reflected B lymphoid activation and lymph node egress, while in ST they reflected local differentiation. Conclusion: Persistently high circulating TIGIT + Tph and Tfh, including Cit-vimentin specificities, reflecting antigen-presenting B-cell interactions, are associated with reduced response to csDMARDs in recent-onset RA. Key messages: What is already known on this topic: Tph and Tfh cells interacting with B cells are implicated in active ACPA+ RA Citrullinated (Cit)-vimentin is an important neutrophil extracellular trap-derived target of ACPA What this study adds: High circulating TIGIT+ Tph, Cit-vimentin-autoreactive Tph and Tfh associate with failure to reach remission on conventional synthetic DMARDs within the first year in early HLA-DR shared-epitope+ RA Tph/Tfh and adjacent regulatory T cells surround follicular B-cells in lymphoid aggregates in synovial tissue in non-remission Circulating TIGIT+ Tph bear a transcriptional signature of lymphoid tissue expansion and lymph node egress as compared to functional differentiation and antigen experience in synovial tissue How this study might affect research, practice or policy: When a remission target is not achieved in HLA-DR shared-epitope+ RA patients during the first year of treatment, high circulating TIGIT+ Tph implicate autoreactive T-B-lymphoid expansion in synovial tissue.

25 July 2026 in Annals of the Rheumatic Diseases
Verified
Journal Article
Open access
IHInez C. Den Hond
Inez C. Den Hond
Marcel ReindersMarcel Reinders
Marcel Reinders
MLMyles J. Lewis
Myles J. Lewis
FRFelice Rivellese
Felice Rivellese
CPCostantino Pitzalis
Costantino Pitzalis
EAErik van den Akker
Erik van den Akker
Rheumatoid arthritis (RA) exhibits clinical and biological heterogeneity, with synovial tissue stratified into histological pathotypes: lympho-myeloid, diffuse-myeloid, and pauci-immune fibroid. Although genome-wide association studies (GWAS) have uncovered RA risk loci, how genetic risk relates to synovial immunopathology remains unclear. To better understand how genetic predisposition may shape divergent early disease mechanisms, we characterised the expression patterns of GWAS-identified RA susceptibility genes and related rheumatic diseases across the synovial pathotypes. Synovial RNA sequencing of patients with early RA (Pathobiology of Early Arthritis Cohort [PEAC] [N = 87] and Flinders [N = 18]) was used for differential gene expression between pathotypes, and pathway enrichment analyses were performed using GWAS-identified susceptibility genes for RA, osteoarthritis (OA), ankylosing spondylitis, psoriatic arthritis, and systemic lupus erythematosus. RA susceptibility gene expression in synovial tissue separated patients by pathotype and correlated with markers of disease activity. RA susceptibility genes were significantly enriched among genes upregulated in lympho-myeloid synovium and linked to lymphocyte activation and differentiation pathways. In contrast, OA susceptibility genes were upregulated in diffuse-myeloid and fibroid synovium. Both patterns were most pronounced in anticitrullinated protein antibody (ACPA)-positive and directionally consistent in ACPA-negative patients. Expression of RA susceptibility genes is not evenly distributed across synovial pathotypes but is strongly biased towards the lympho-myeloid pathotype, indicating that current GWAS signals preferentially capture immune-driven disease mechanisms. Enrichment of OA susceptibility genes in diffuse-myeloid and fibroid pathotypes, even among ACPA-positive patients, suggests shared biological features between autoimmune and noninflammatory degenerative joint diseases in certain RA subtypes. Synovial pathotype stratification is therefore essential for interpreting genetic risk and understanding disease heterogeneity.